The Lee Kong Chian School of Medicine (LKCMedicine) trains
doctors who put patients at the centre of their exemplary care. The
School, which offers both undergraduate and graduate programmes, is
named after local philanthropist Tan Sri Dato Lee Kong Chian.
Established in 2010 by Nanyang Technological University, Singapore,
in partnership with Imperial College London, LKCMedicine aims to be
a model for innovative medical education and a centre for
transformative research. The School's primary clinical partner is
the National Healthcare Group, a leader in public healthcare
recognised for the quality of its medical expertise, facilities and
teaching. The School is transitioning to an NTU medical school
ahead of the 2028 successful conclusion of the NTU-Imperial
partnership to set up a Joint Medical School. In August 2024, we
welcomed our first intake of the NTU MBBS programme, that has been
recently enhanced to include themes like precision medicine and
Artificial Intelligence (AI) in healthcare, with an expanded scope
in the medical humanities. Graduates from the five-year
undergraduate medical degree programme will have a strong
understanding of the scientific basis of medicine, with an emphasis
on technology, data science and the
humanities.
The Molecular and Cellular
Dysfunction in Diabetes Laboratory, led by Associate Professor
Yusuf Ali, combines in vitro systems biology, advanced imaging, in
vivo models and multi-omics technologies to elucidate pathways
critical to type 2 diabetes mellitus pathogenesis, with focus on
pancreatic and immune function. The team is moving into molecular
nutrition, harnessing the power of novel ingredients and prebiotics
to mitigate the rise of persons living with diabetes. A laboratory
under the Nutrition, Metabolism and Health programme, our work
seeks for causality so that we can translate mechanistic insights
into therapeutic strategies for mitigating type 2 diabetes and
related metabolic conditions.
For more details,
https : / / dr.ntu.edu.sg / cris / rp / rp00609
are seeking a passionate and motivated Research Fellow to
contribute to a high-impact project exploring how intracellular
lipid regulation is altered under different diets and how the
endocrine pancreas can be better protected under obesity and
metabolically dysregulated conditions. As type 2 diabetes is also a
condition of low grade chronic inflammation, expertise on studying
how circulating immune cells interact with tissue-specific immune
cells will be a plus. The project investigates molecular mechanisms
underpinning cell stress and resilience, integrating in vitro and
in vivo studies using genetically modified mouse models, human
islets, and multi-omics approaches. This position is ideal for
researchers with a strong interest in lipid metabolism,
autophagy / lipophagy, and diabetes
Responsibilities : Conduct various in
vitro assays / experiments, including histology, western blotting,
immunofluorescence microscopy, etc.
vivo experiments, animal studies
biology to integrate results and generate list of perturbed
Contribute to research grant proposal
applications, including literature review and preliminary
Contribute to research deliverables, such
as manuscript writing, attending local and / or international
undergraduate / PhD students and junior research staff
Collaborate effectively with the research teams to
achieve overall research goals and
qualification, experience, skills and
Biomedical Sciences, or related field
2-3 years of relevant experience in molecular biology, cell
culture, imaging, or metabolic disease models
Strong technical proficiency in laboratory techniques
such as immunoblotting, immunofluorescence microscopy, qPCR, and
standards, good laboratory practices and experience with IACUC
communication skills, with demonstrated ability to draft scientific
organizational, motivational and self-driven skills, with a
with strong experimental skills and interest in metabolic disease
Research Fellow • Singapore